China begins human trial on another potential Covid-19 antibody therapy | The Business Standard
Skip to main content
  • Epaper
  • Economy
    • Aviation
    • Banking
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
The Business Standard

Sunday
June 01, 2025

Sign In
Subscribe
  • Epaper
  • Economy
    • Aviation
    • Banking
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
SUNDAY, JUNE 01, 2025
China begins human trial on another potential Covid-19 antibody therapy

Coronavirus chronicle

TBS Report
09 June, 2020, 09:15 pm
Last modified: 09 June, 2020, 09:19 pm

Related News

  • Children have stronger antibody response to Covid: Study
  • Covid-19 antibody surveys underestimate infections: Study
  • Preliminary results show Chinese Covid-19 vaccine candidate safe
  • Antibody drugs are no cure but seem promising for Covid-19
  • US warns of fraudulent coronavirus antibody tests

China begins human trial on another potential Covid-19 antibody therapy

There are several other companies trying to create antibody therapies to fight Covid-19, including Regeneron Pharmaceuticals, which has said it expects to begin clinical trials this month

TBS Report
09 June, 2020, 09:15 pm
Last modified: 09 June, 2020, 09:19 pm
China begins human trial on another potential Covid-19 antibody therapy

An antibody treatment developed by Eli Lilly and Chinese company Junshi Biosciences to fight Covid-19 was dosed to a healthy volunteer on Monday.

The trial is underway in China, Lilly will start a complementary Phase one study in the United States in the next few days, the company said, reports the CNN.

Scientists will first test to see if this antibody treatment, called JS016, is safe to be used in humans. If so, it will be tested to see if it if effective. 

The Business Standard Google News Keep updated, follow The Business Standard's Google news channel

If this first phase is successful, more trials will run to determine how to use it most effectively. 

The companies will also experiment to see if the antibody could be used on its own or if it would be more effective used in combination with other antibody candidates. JS016 appeared to neutralize the virus in the lab. Lilly and Junshi scientists are testing other potential antibodies in the lab to see which work best. 

This is the second such antibody therapy trial from the Indianapolis-based pharmaceutical company. Lilly is testing another antibody treatment called LY-COV555 that the company developed with AbCellera.

Junshi Biosciences is leading development in greater China, according to Lilly, and Eli Lilly has exclusive rights to it in the rest of the world.

There are several other companies trying to create antibody therapies to fight Covid-19, including Regeneron Pharmaceuticals, which has said it expects to begin clinical trials this month.

Antibodies are proteins your body makes in the thousands that naturally fight off infection. To make an antibody therapy, scientists have to sort through thousands of antibodies to determine which work best to neutralize a particular threat.

Typically, drug developers will pick one and then clone it until there are enough monoclonal antibodies to put in a medicine.

Antibody treatments are currently used to treat some cancers, eye problems, chronic and infectious disease. The treatments can be used to treat symptoms or potentially as a protective medicine to prevent infection in vulnerable populations like the elderly or in health care workers.

coronavirus antibody

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • Former prime minister Sheikh Hasina briefing media. File Photo: UNB
    Prosecution files formal charges at ICT against Hasina, 2 others over July Uprising atrocities
  • Chief Adviser Muhammad Yunus speaking at the inaugural session of the "China-Bangladesh Conference on Investment and Trade" in the capital on 1 June 2025. Photo: UNB
    CA Yunus urges Chinese investors to help build a sky-high future
  • Government officials gathered at Badam Tola premises in Secretariat demanding repeal of Public Service (Amendment) Ordinance on 1 June 2025. Photo: TBS
    Officials protest at Secretariat, set to submit memo to 3 advisers today seeking repeal of Public Service Ordinance

MOST VIEWED

  • Govt slashes June prices for diesel, petrol, octane
    Govt slashes June prices for diesel, petrol, octane
  • Tax exemptions for key industries to go, sweeping tax hikes planned
    Tax exemptions for key industries to go, sweeping tax hikes planned
  • Photo: Courtesy
    IFIC Bank incurs Tk500cr loss in Jan-Mar
  • Chief Adviser Muhammad Yunus meets Japanese Prime Minister Ishiba Shigeru in Japan on 30 May 2025. Photo: CA Office
    Bangladesh, Japan to sign Economic Partnership Agreement by year-end
  • Indian Chief of Defence Staff General Anil Chauhan shares insights on how Operation Sindoor represents future wars at Shangri-la Dialogue in Singapore on Saturday, 31 May 2025. Photo: ANI via Hindustan Times
    India confirms losing fighter jets in recent conflict with Pakistan: Bloomberg
  • Mahmud Hasan Khan Babu. Photo: Collected
    Mahmud-led Forum panel wins BGMEA election

Related News

  • Children have stronger antibody response to Covid: Study
  • Covid-19 antibody surveys underestimate infections: Study
  • Preliminary results show Chinese Covid-19 vaccine candidate safe
  • Antibody drugs are no cure but seem promising for Covid-19
  • US warns of fraudulent coronavirus antibody tests

Features

The wide fenders, iconic hood scoop and unmistakable spoiler are not just cosmetic; they symbolise a machine built to grip dirt, asphalt and hearts alike. PHOTO: Akif Hamid

Resurrecting the Hawkeye: A Subaru WRX STI rebuild

4h | Wheels
Babar Ali, Ikramul Hasan Shakil, and Wasfia Nazreen are leading a bold resurgence in Bangladeshi mountaineering, scaling eight-thousanders like Everest, Annapurna I, and K2. Photos: Collected

Back to 8000 metres: How Bangladesh’s mountaineers emerged from a decade-long pause

1d | Panorama
Photos: Courtesy

Behind the looks: Bangladeshi designers shaping celebrity fashion

1d | Mode
Photo collage of the sailors and their catch. Photos: Shahid Sarkar

Between sky and sea: The thrilling life afloat on a fishing ship

2d | Features

More Videos from TBS

Israeli ban halts West Bank visit by foreign ministers of five Arab countries, including Saudi Arabia

Israeli ban halts West Bank visit by foreign ministers of five Arab countries, including Saudi Arabia

33m | TBS World
Charges Filed Against Sheikh Hasina at ICT

Charges Filed Against Sheikh Hasina at ICT

1h | TBS Today
What do lawyers say about the ruling on Jamaat's registration?

What do lawyers say about the ruling on Jamaat's registration?

3h | TBS Today
Fuel prices cut; effective from June 1

Fuel prices cut; effective from June 1

14h | TBS News Updates
EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Advertisement
  • Privacy Policy
  • Comment Policy
Copyright © 2025
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net